Oxford Haemodynamic Adaptation to Reduce Pulsatility Trial

Condition:   Small Vessel Cerebrovascular Disease Interventions:   Drug: Sildenafil;   Drug: Cilostazol;   Drug: Placebo Sponsors:   University of Oxford;   Wellcome Trust Not yet recruiting

Source: ClinicalTrials.gov - February 26, 2019 Category: Research Source Type: clinical trials